CD274 and neoplasm: TNBC has been shown to have a higher proportion of tumor infiltrating lymphocytes (TILs)13–15 compared to other subtypes, relatively high tumor mutational burden16 and PD-L1 expression17, and survival associations with degree of T cell and B cell infiltration18, making immunotherapy a promising option against this disease.